Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application

Real-Time Quote  
Real-Time Quote Not Available Why not?
Real-Time Quote Only available during pre-market and regular market hours. about
  • Day Low  4.75 12:33 PM EST  
    Day High 4.90 10:06 AM EST
    Range 0.15  
    Volume 87,311  
    30-Day Avg Vol 187,000
    Difference -53.31%  
    Market Cap 203.96 M  
    Mkt Cap Chg 3.37 M  
    Shares Out 42.22 M  
    % Shrs Traded 0.21%  
    1yr EPS Est -0.203  
    52-Wk Low 3.20
    52-Wk High 9.32
    Range 6.12  
    Prev Close 4.75 11/20/09  
    Today's Open 4.80  
    Change 1.05%
    Dividend (TTM) 0.00  
    Div Yield (TTM) 0.00%
    Ex-Div Date
    Div Date
    Short Interest 1.71 M

    Performance Details

    Revenue (LFY) 63.72 M  
    Earnings (LFY) 15.35 M  
    Earnings (MRQ) -1.31 M  
    Next Earn Est -0.03  
    Next Earnings 11/11/2009
    EPS (TTM) -0.11  
    1yr EPS Growth -103.00%  
    P/E Ratio (TTM)  
    P/E Ratio (Fwd) -23.00  
    PEG Ratio  
    Return on Equity 15.22  
    Beta 0.51  
    Sector Healthcare  
    Industry Drugs  
    Click icons above for more info
  • Set and Manage Alerts

    Alert me if
  • Blog Posts: PTIE

    Blogs are not currently available for ptie.

    View all blogs at BloggingStocks.

  • Related Information: PTIE

    Company Overview: PTIE

    Pain Therapeutics is providing opiates for the masses. The development-stage company is working on abuse-resistant painkillers, including Remoxy, a version of the frequently abused Oxycontin. Pain Therapeutics ... View Full Description

    Earnings Analysis: PTIE

    Analyst Consensus

    • Strong Buy
    • Buy
    • Hold
    • Sell
    • Strong Sell
    Earnings/Share(EPS) Estimate Actual Difference
    Next Quarter -0.03 N/A
    Last Quarter -0.03 9/30/09 -0.03 9/30/09 0.00
    Met
    2 Quarters Ago -0.057 6/30/09 0.00 6/30/09 0.057
    Beat

    Financials: PTIE

      Quarterly - 09/30/2009 Annual - 2008
    Total Revenue 3.76 M 63.72 M
    Gross Profit 3.70 M 63.27 M
    Operating Income -2.29 M 8.71 M
    Net Income -1.31 M 15.35 M